Sally Mandour/LinkedIn
Aug 13, 2026, 08:23
Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure
Sally Mandour, Associate Professor, Head of Hematology Unit at Clinical Pathology Department of National Liver Institute, Monofeya University, shared a post on LinkedIn:
“Aplastic Anaemia is defined by the presence of pancytopenia with an empty bone marrow , by exclusion of marrow aplasia due to direct effect of chemotherapy or radiotherapy or any underlying pathological marrow condition.
Diagnosis difficulty is due to the number of marrow failure syndromes having a similar presentation.
Aplastic Anaemia vs. Hypoplastic MDS: Two Empty Marrows, Two Very Different Diseases
- Both present with pancytopenia and a ’empty,’ fat-replaced marrow.
- Both are driven by an oligoclonal CD8+ T-cell attack on haematopoietic stem cells. On a low-power view.
But one is an autoimmune bone marrow failure state. The other is a clonal neoplasm
5 differentiating tips:
- Dysplasia — subtle dysgranulopoiesis, megakaryocyte atypia, or ring sideroblasts favour MDS-h; a ‘clean’ hypoplastic marrow favours AA.
- Blasts — even a mildly increased blast percentage tips the scale toward MDS-h.
- Cytogenetics — clonal abnormalities (del(5q), del(7q), trisomy 8, del(20q)) support MDS-h; a normal karyotype supports AA (though AA is not always normal either).
- Molecular profile — BCOR/BCORL1 and PIGA mutations are typically ‘benign passengers’ in AA and predict a good response to immunosuppression. TP53, RUNX1, and multi-hit mutations point toward MDS-h/high-risk disease.
- PNH clone — a sizeable PNH clone (flow cytometry: CD55/CD59/FLAER) supports immune-mediated AA rather than MDS-h.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments